leuprolide and Bone-Demineralization--Pathologic

leuprolide has been researched along with Bone-Demineralization--Pathologic* in 1 studies

Trials

1 trial(s) available for leuprolide and Bone-Demineralization--Pathologic

ArticleYear
Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain.
    Fertility and sterility, 2006, Volume: 86, Issue:1

    This pilot study examined the effect of a low-dose E and pulsed progestogen hormone therapy (HT) regimen for add-back during long-term GnRH-agonist therapy on bone mineral density (BMD) in five patients with stage IV endometriosis. Bone mineral density was stable after initiation of HT for the entire follow-up period (up to 10 years). One patient stopped her treatment on two occasions to conceive and was successful each time with delivery of a normal baby. No patient had return of pelvic pain after HT add-back.

    Topics: Adult; Bone Demineralization, Pathologic; Bone Density; Chronic Disease; Drug Combinations; Endometriosis; Estradiol; Female; Fertility Agents, Female; Hormone Replacement Therapy; Humans; Leuprolide; Pelvic Pain; Pilot Projects; Progestins; Treatment Outcome

2006